Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial (vol 17, pg 425, 2016) | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

6322947

Reference Type

Journal Article

Title

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial (vol 17, pg 425, 2016)

Author(s)

Cristofanilli, M; Turner, NC; Bondarenko, I

Year

2016

Is Peer Reviewed?

Journal

The Lancet Oncology
ISSN: 1470-2045
EISSN: 1474-5488

Volume

Issue

Page Numbers

E136-E136

Web of Science Id

WOS:000373497600014